Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

COVID-19 lab safety considerations when re-opening the lab


Will Oldham
Christine Scherp, MD

Description

While California has extended its shelter-in-place order through the end of May, some San Francisco, Bay Area laboratories might be permitted to re-open in a few weeks. As we think about preparing to re-activate Mission Bio operations, when state clearance is provided and it is safe to do so, there are numerous things to consider when reinstating a lab while adhering to safety and health guidelines. Join a discussion with our leaders from Manufacturing and Quality to hear about some of the things we are considering before we re-open our labs.



VIEW


Scientific presentation
AML Single-cell Multi-omics MRD (scMRD) and the Horizon of Clinical Utility
Aaron Llanso
AMP 2022 (2022)
Scientific presentation
Molecular Analysis of Acute Myeloid Leukemia in Morphologic Remission
Sanam Loghavi, MD
AMP 2022 (2022)
Scientific presentation
Considerations, Strategies, and Advances in Early Drug Development to Mitigate Clinical Holds and Achieve Successful CGT Outcomes
Azadeh Golipour, PhD, AVROBIO
J. Kelly Ganjei, AmplifyBio
Scott R. Burger, MD, Advanced Cell and Gene Therapy
Matthew Cato
(2022)
Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE